Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001193125-18-244474
Filing Date
2018-08-09
Accepted
2018-08-09 16:47:41
Documents
2

Document Format Files

Seq Description Document Type Size
1 425 d602428d425.htm 425 65141
2 GRAPHIC g602428g76g65.jpg GRAPHIC 15648
  Complete submission text file 0001193125-18-244474.txt   88308
Mailing Address ONE MARINA PARK DR. BOSTON MA 02210
Business Address ONE MARINA PARK DR. BOSTON MA 02210 617-466-3500
KERYX BIOPHARMACEUTICALS INC (Subject) CIK: 0001114220 (see all company filings)

EIN.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 000-30929 | Film No.: 181005994
SIC: 2834 Pharmaceutical Preparations

Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Filed by) CIK: 0001517022 (see all company filings)

EIN.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations